MGUS is grouped into three main groups based on the antibody subtype. The three groups have different symptoms and syndromes if they progress to multiple myeloma. Remember, MGUS very rarely has ...

Monoclonal gammopathy of undetermined significance (MGUS) is not cancer. There’s a small risk it can become cancer. Out of every 100 people with MGUS, each year, 1 or 2 of them will get cancer from ...

According to data from a population-based study, monoclonal gammopathy of undetermined significance was significantly associated with only 14 diseases, not 75 as previously believed. These results ...

First, both are more prevalent than they believed, at least among the people of Iceland—MGUS was found among .5% of the population over age 40. And second, SMM is also more common than was known ...

Two recent papers shine a light on monoclonal gammopathy of undetermined significance (MGUS), a premalignant condition that is prevalent in the general population, affecting about 3% of ...

Multiple myeloma represents a spectrum of disease, ranging from monoclonal gammopathy of undetermined significance (MGUS); to smoldering myeloma; to frank, overt, or ...

People with M proteins in their blood may have MGUS, which is a noncancerous condition. In some cases, MGUS can lead to multiple myeloma or other cancers. However, M proteins can also indicate SMM.

Monoclonal gammopathy of undetermined significance, or MGUS (pronounced "EM-guss"), is a noncancerous condition that can evolve into myeloma. Researchers have discovered that if you’re Black ...

Histological senescence analysis of diagnostic bone marrow biopsies from patients with MGUS, SMM, or newly diagnosed MM (NDMM). Credit: Leukemia (2025). DOI: 10.1038/s41375-025-02572-z ...

Rheumatology > General Rheumatology Doubt Cast on MGUS-Autoimmune Disease Link — Population-based study fails to confirm earlier findings. by John Gever, Contributing Writer, MedPage Today May ...

Monoclonal gammopathy of undetermined significance (MGUS) is defined by the presence of a monoclonal protein in persons with no features of multiple myeloma or other related malignant disorders ...

The prevalence of monoclonal gammopathy of undetermined significance (MGUS), a premalignant plasma-cell disorder, among persons 50 years of age or older has not been accurately determined. We used ...